Hepatocellular Carcinoma and Transarterial Chemo-Embolization

The most well-known kind of adult essential liver growth and the most common cause of death in cirrhotic people is hepatocellular carcinoma (HCC). It occurs when the liver is constantly becoming worse and is most strongly linked to chronic viral hepatitis infection (hepatitis B or C) or exposure to toxins like alcohol or aflatoxin. Alpha 1-antitrypsin deficiency and hemochromatosis are two conditions that increase the risk of treating HCC. Similar to other malignancies, HCC therapy and prognosis depend on the characteristics of the, tumor's histology measurement, extent of growth, and overall health.

 

    Related Conference of Hepatocellular Carcinoma and Transarterial Chemo-Embolization

    September 19-20, 2024

    19th Euro-Global Gastroenterology Conference

    Paris, France
    November 21-22, 2024

    23rd World Congress on Gastrointestinal Cancer

    Dubai, UAE
    March 10-11, 2025

    8th International Congress on Viral Hepatitis

    Paris, France
    March 13-14, 2025

    13th International Conference on Gynecology and Obstetrics

    Prague, Czech Republic

    Hepatocellular Carcinoma and Transarterial Chemo-Embolization Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in